Health Insurance Innovations Clears Key Benchmark, Hitting 90-Plus RS Rating

A generic image of a pen on top of a stock chart. Credit: Shutterstock photo

Health Insurance Innovations ( HIIQ ) had its Relative Strength ( RS ) Rating upgraded from 86 to 92 Wednesday.

[ibd-display-video id=2881825 width=50 float=left autostart=true] IBD's unique rating identifies share price performance with a 1 (worst) to 99 (best) score. The rating shows how a stock's price movement over the last 52 weeks stacks up against all the other stocks in our database.

Over 100 years of market history reveals that the market's biggest winners often have an 80 or higher RS Rating in the early stages of their moves.

See How IBD Helps You Make More Money In Stocks

Health Insurance Innovations has climbed more than 5% past a 21.10 entry in a first-stage cup without handle , meaning it's now out of a proper buy zone. Look for the stock to offer a new chance to get in like a three-weeks tight or pullback to the 50-day or 10-week moving average.

Health Insurance Innovations reported 39% EPS growth in the latest quarterly report. Revenue rose 37%.

The company earns the No. 3 rank among its peers in the Insurance-Brokers industry group. Fanhua ( FANH ) is the No. 1-ranked stock within the group.

RELATED:

Which Stocks Are Showing Rising Relative Strength?

Why Should You Use IBD's Relative Strength Rating?

How Relative Strength Line Can Help You Judge A Stock

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

More Related Articles

Info icon

This data feed is not available at this time.

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.